On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...